Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ajic.2011.05.020
DC FieldValue
dc.titleInternational Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009
dc.contributor.authorRosenthal, V.D.
dc.contributor.authorBijie, H.
dc.contributor.authorMaki, D.G.
dc.contributor.authorMehta, Y.
dc.contributor.authorApisarnthanarak, A.
dc.contributor.authorMedeiros, E.A.
dc.contributor.authorLeblebicioglu, H.
dc.contributor.authorFisher, D.
dc.contributor.authorÁlvarez-Moreno, C.
dc.contributor.authorKhader, I.A.
dc.contributor.authorDel Rocío González Martínez, M.
dc.contributor.authorCuellar, L.E.
dc.contributor.authorNavoa-Ng, J.A.
dc.contributor.authorAbouqal, R.
dc.contributor.authorGuanche Garcell, H.
dc.contributor.authorMitrev, Z.
dc.contributor.authorPirez García, M.C.
dc.contributor.authorHamdi, A.
dc.contributor.authorDueñas, L.
dc.contributor.authorCancel, E.
dc.contributor.authorGurskis, V.
dc.contributor.authorRasslan, O.
dc.contributor.authorAhmed, A.
dc.contributor.authorKanj, S.S.
dc.contributor.authorUgalde, O.C.
dc.contributor.authorMapp, T.
dc.contributor.authorRaka, L.
dc.contributor.authorYuet Meng, C.
dc.contributor.authorThu, L.T.A.
dc.contributor.authorGhazal, S.
dc.contributor.authorGikas, A.
dc.contributor.authorNarváez, L.P.
dc.contributor.authorMejía, N.
dc.contributor.authorHadjieva, N.
dc.contributor.authorGamar Elanbya, M.O.
dc.contributor.authorGuzmán Siritt, M.E.
dc.contributor.authorJayatilleke, K.
dc.date.accessioned2016-09-06T08:41:47Z
dc.date.available2016-09-06T08:41:47Z
dc.date.issued2012-06
dc.identifier.citationRosenthal, V.D., Bijie, H., Maki, D.G., Mehta, Y., Apisarnthanarak, A., Medeiros, E.A., Leblebicioglu, H., Fisher, D., Álvarez-Moreno, C., Khader, I.A., Del Rocío González Martínez, M., Cuellar, L.E., Navoa-Ng, J.A., Abouqal, R., Guanche Garcell, H., Mitrev, Z., Pirez García, M.C., Hamdi, A., Dueñas, L., Cancel, E., Gurskis, V., Rasslan, O., Ahmed, A., Kanj, S.S., Ugalde, O.C., Mapp, T., Raka, L., Yuet Meng, C., Thu, L.T.A., Ghazal, S., Gikas, A., Narváez, L.P., Mejía, N., Hadjieva, N., Gamar Elanbya, M.O., Guzmán Siritt, M.E., Jayatilleke, K. (2012-06). International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. American Journal of Infection Control 40 (5) : 396-407. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ajic.2011.05.020
dc.identifier.issn01966553
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/126824
dc.description.abstractThe results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in 422 intensive care units (ICUs) of 36 countries in Latin America, Asia, Africa, and Europe are reported. During the 6-year study period, using Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system [NNIS]) definitions for device-associated health care-associated infections, we gathered prospective data from 313,008 patients hospitalized in the consortium's ICUs for an aggregate of 2,194,897 ICU bed-days. Despite the fact that the use of devices in the developing countries' ICUs was remarkably similar to that reported in US ICUs in the CDC's NHSN, rates of device-associated nosocomial infection were significantly higher in the ICUs of the INICC hospitals; the pooled rate of central line-associated bloodstream infection in the INICC ICUs of 6.8 per 1,000 central line-days was more than 3-fold higher than the 2.0 per 1,000 central line-days reported in comparable US ICUs. The overall rate of ventilator-associated pneumonia also was far higher (15.8 vs 3.3 per 1,000 ventilator-days), as was the rate of catheter-associated urinary tract infection (6.3 vs. 3.3 per 1,000 catheter-days). Notably, the frequencies of resistance of Pseudomonas aeruginosa isolates to imipenem (47.2% vs 23.0%), Klebsiella pneumoniae isolates to ceftazidime (76.3% vs 27.1%), Escherichia coli isolates to ceftazidime (66.7% vs 8.1%), Staphylococcus aureus isolates to methicillin (84.4% vs 56.8%), were also higher in the consortium's ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 7.3% (for catheter-associated urinary tract infection) to 15.2% (for ventilator-associated pneumonia). Copyright © 2012 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ajic.2011.05.020
dc.sourceScopus
dc.subjectAntibiotic resistance
dc.subjectBloodstream infection
dc.subjectCatheter-associated urinary tract infection
dc.subjectCentral line-associated bloodstream infection
dc.subjectDeveloping countries
dc.subjectDevice-associated infection
dc.subjectHealth care-associated infection
dc.subjectHospital infection
dc.subjectLimited-resources countries
dc.subjectLow-income countries
dc.subjectNetwork
dc.subjectNosocomial infection
dc.subjectUrinary tract infection
dc.subjectVentilator-associated pneumonia
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1016/j.ajic.2011.05.020
dc.description.sourcetitleAmerican Journal of Infection Control
dc.description.volume40
dc.description.issue5
dc.description.page396-407
dc.description.codenAJICD
dc.identifier.isiut000304378300003
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

318
checked on May 18, 2022

WEB OF SCIENCETM
Citations

298
checked on May 18, 2022

Page view(s)

132
checked on May 12, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.